← SynDRA
Cenisertib
SynDRA canonical compound SYN0971327 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AURKB | KDR |
|---|
| Mechanism of action | aurora kinase inhibitor |
|---|
| Indication | pancreatic cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- AURKB INHIBITOR
- Serine/threonine-protein kinase Aurora inhibitor
- AURKC INHIBITOR
- AURKA INHIBITOR
- KDR INHIBITOR
- aurora kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- AS703569
- AS 703569
- R 763
- R763
- Aurora kinase inhibitor as703569
- cenisertibum
- RefChem:124323
- DTXCID20158638
- Cenisertib R763
- Cenisertib [INN]
- UNII-5277GPA358
- AS-703569;R-763
- CENISERTIB [WHO-DD]
- SCHEMBL400147
- GTPL9927
- orb1707472
- SCHEMBL30097376
- KSOVGRCOLZZTPF-QMKUDKLTSA-N
- BDBM50389967
- EX-A14832
- NSC763930
- AKOS040741531
- compound 2 [PMID: 22695126]
- EBC-220181
- NSC-763930
- compound 60a [WO2005118544A2]
- enantiomer E1 [WO2005118544A2]
- HY-13072
- MS-28200
- DB-344506
- CS-0003175
- G14148
- T14925
- AS-703569 benzoate
- S68QU67MAZ
- CS-1229259
- RefChem:124324
- SCHEMBL29524626
Look up Cenisertib in the interactive SynDRA portal →